Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Affibody Molecules for Targeted Radionuclide Therapy
KTH, School of Biotechnology (BIO), Molecular Biotechnology.ORCID iD: 0000-0002-9282-0174
KTH, School of Biotechnology (BIO), Molecular Biotechnology.
Rudbeck Lab, Uppsala University.
Rudbeck Lab, Uppsala University.
Show others and affiliations
2011 (English)In: Targeted Radionuclide Therapy: Immunology and Targeted Constructs / [ed] Tod W. Speer, Philadelphia, USA: Lippincott Williams & Wilkins, 2011, 49-58 p.Chapter in book (Refereed)
Place, publisher, year, edition, pages
Philadelphia, USA: Lippincott Williams & Wilkins, 2011. 49-58 p.
National Category
Medical Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-60665ISBN: 978-0-7817-9693-4 (print)OAI: oai:DiVA.org:kth-60665DiVA: diva2:477672
Note
QC 20120116Available from: 2012-01-13 Created: 2012-01-13 Last updated: 2012-01-16Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Ståhl, Stefan

Search in DiVA

By author/editor
Ståhl, StefanFriedman, MikaelaFrejd, Fredrik
By organisation
Molecular Biotechnology
Medical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf